CHARLES MANGO, M.D.
Ophthalmology Physician · BRONXVILLE, NY
Individual Active NPI 1528025129
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,127 | 14,647 | $6,440,120 | $2,396,202 | $1,863,695 |
| 2023 | 1,023 | 10,644 | $5,764,645 | $2,183,481 | $1,718,810 |
| 2022 | 578 | 5,848 | $4,347,730 | $1,608,940 | $1,265,448 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 4,440 | $34 | $27 |
| 92134 | Imaging of retina | 2,370 | $45 | $33 |
| J0178 | Injection, aflibercept, 1 mg | 1,704 | $815 | $649 |
| 92201 | Extended exam of the back part of the eye with retinal drawing | 1,312 | $27 | $20 |
| 67028 | Injection of drug into eye | 1,051 | $127 | $94 |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 1,010 | $103 | $73 |
| J0177 | Injection, aflibercept hd, 1 mg | 624 | $322 | $257 |
| 92014 | Established patient complete exam of visual system | 598 | $141 | $96 |
| 92250 | Photography of the retina | 454 | $41 | $31 |
| 92012 | Established patient problem focused exam of visual system | 444 | $97 | $73 |
| 92004 | New patient complete exam of visual system | 157 | $167 | $117 |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | 82 | $17 | $13 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | 223862-1 | NY |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in New York
- NPI 1538275425
- NPI 1073094306
- NPI 1144248964
- NPI 1730295627
- NPI 1942628516
- NPI 1457342123
- NPI 1679237788
- NPI 1952845448
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.